These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25053853)

  • 1. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
    Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
    Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
    Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
    Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
    Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.
    Vellimana AK; Recinos VR; Hwang L; Fowers KD; Li KW; Zhang Y; Okonma S; Eberhart CG; Brem H; Tyler BM
    J Neurooncol; 2013 Feb; 111(3):229-36. PubMed ID: 23224713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
    Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
    J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model.
    Serra R; Mangraviti A; Gorelick NL; Shapira-Furman T; Alomari S; Cecia A; Darjee N; Brem H; Rottenberg Y; Domb AJ; Tyler B
    Eur J Pharm Biopharm; 2022 Jan; 170():179-186. PubMed ID: 34968646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
    Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A
    Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
    Recinos VR; Bekelis K; Ziegler SG; Vick D; Hertig S; Tyler BM; Li KW; Kosztowski T; Legnani FG; Brem H; Olivi A
    J Neurooncol; 2010 Mar; 97(1):1-10. PubMed ID: 19693439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.
    McGirt MJ; Than KD; Weingart JD; Chaichana KL; Attenello FJ; Olivi A; Laterra J; Kleinberg LR; Grossman SA; Brem H; Quiñones-Hinojosa A
    J Neurosurg; 2009 Mar; 110(3):583-8. PubMed ID: 19046047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
    Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
    Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models.
    Grossman R; Brastianos H; Blakeley JO; Mangraviti A; Lal B; Zadnik P; Hwang L; Wicks RT; Goodwin RC; Brem H; Tyler B
    J Neurooncol; 2014 Jan; 116(1):59-65. PubMed ID: 24185441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
    Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
    J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.
    Ulasov I; Thaci B; Sarvaiya P; Yi R; Guo D; Auffinger B; Pytel P; Zhang L; Kim CK; Borovjagin A; Dey M; Han Y; Baryshnikov AY; Lesniak MS
    Cancer Med; 2013 Aug; 2(4):457-67. PubMed ID: 24156018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.
    Masi BC; Tyler BM; Bow H; Wicks RT; Xue Y; Brem H; Langer R; Cima MJ
    Biomaterials; 2012 Aug; 33(23):5768-75. PubMed ID: 22591609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection.
    Akbar U; Jones T; Winestone J; Michael M; Shukla A; Sun Y; Duntsch C
    J Neurooncol; 2009 Sep; 94(2):203-12. PubMed ID: 19337695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of temozolomide delivered by prolonged intracerebral microinfusion against the rat brainstem GBM allograft model.
    Yoshimura J; Siu IM; Thomale UW; Jallo GI
    Childs Nerv Syst; 2012 May; 28(5):707-13. PubMed ID: 22391876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.
    Banissi C; Ghiringhelli F; Chen L; Carpentier AF
    Cancer Immunol Immunother; 2009 Oct; 58(10):1627-34. PubMed ID: 19221744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.